ONCT-534

· Oncternal Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ONCT-534, covering 2024-12-11 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer. [Phase 1, Phase 2]